These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12236927)

  • 1. [Prevention and treatment of ischemic heart disease in patients with diabetes mellitus].
    Bueno H
    Rev Esp Cardiol; 2002 Sep; 55(9):975-86. PubMed ID: 12236927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of patients with ischemic heart disease and diabetes].
    Zaliūnas R; Babarskiene MR; Brazdzionyte J
    Medicina (Kaunas); 2004; 40(2):192-7. PubMed ID: 15007279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The platelet in diabetes: focus on prevention of ischemic events.
    Colwell JA; Nesto RW
    Diabetes Care; 2003 Jul; 26(7):2181-8. PubMed ID: 12832332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: glycoprotein IIb/IIIa inhibitors, clopidogrel, or both?
    Silva MA; Donovan JL; Gandhi PJ; Volturo GA
    Vasc Health Risk Manag; 2006; 2(1):39-48. PubMed ID: 17319468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing acute coronary syndrome: evidence-based approaches.
    Spinler SA
    Am J Health Syst Pharm; 2007 Jun; 64(11 Suppl 7):S14-24. PubMed ID: 17519441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelines.
    Spinler SA; Hilleman DE; Cheng JW; Howard PA; Mauro VF; Lopez LM; Munger MA; Gardner SF; Nappi JM
    Ann Pharmacother; 2001 May; 35(5):589-617. PubMed ID: 11346067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to improve the cardiac prognosis for diabetes.
    Herlitz J; Malmberg K
    Diabetes Care; 1999 Mar; 22 Suppl 2():B89-96. PubMed ID: 10097907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approaches to prevention of cardiovascular complications and events in diabetes mellitus.
    Coccheri S
    Drugs; 2007; 67(7):997-1026. PubMed ID: 17488145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute coronary syndromes and diabetes mellitus.
    Trichon BH; Roe MT
    Diab Vasc Dis Res; 2004 May; 1(1):23-32. PubMed ID: 16305052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes mellitus, glycoprotein IIb/IIIa blockade, and heparin: evidence for a complex interaction in a multicenter trial. EPILOG Investigators.
    Kleiman NS; Lincoff AM; Kereiakes DJ; Miller DP; Aguirre FV; Anderson KM; Weisman HF; Califf RM; Topol EJ
    Circulation; 1998 May; 97(19):1912-20. PubMed ID: 9609084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic specific aspects in antithrombotic therapy in patients with coronary artery disease.
    Farhan S; Höchtl T; Wojta J; Huber K
    Minerva Med; 2010 Aug; 101(4):239-53. PubMed ID: 21030936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The clinical use of the GPIIb/IIIa inhibitors eptifibatide and tirofiban in the treatment of acute coronary syndromes of the "non-ST elevation" type].
    Galli M; Maggioni AP; Vassanelli C; Tavazzi L
    Ital Heart J Suppl; 2000 Feb; 1(2):202-11. PubMed ID: 10731377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes and acute coronary syndromes.
    Roffi M; Eberli FR
    Best Pract Res Clin Endocrinol Metab; 2009 Jun; 23(3):305-16. PubMed ID: 19520305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide.
    Goodman SG; Fitchett D; Armstrong PW; Tan M; Langer A;
    Circulation; 2003 Jan; 107(2):238-44. PubMed ID: 12538422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of coronary insufficiency in diabetics: Part 2: acute coronary insufficiency].
    Grand A
    Ann Cardiol Angeiol (Paris); 1999 Feb; 48(2):119-27. PubMed ID: 12555336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic strategies to improve the outcome of patients with diabetes mellitus and acute coronary syndrome].
    Cavallini C
    G Ital Cardiol (Rome); 2006 Apr; 7(4 Suppl 1):13S-20S. PubMed ID: 16749287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive treatment of coronary artery disease in diabetic patients in clinical practice: results of the MITRA study.
    Gitt AK; Schiele R; Wienbergen H; Zeymer U; Schneider S; Gottwik MG; Senges J;
    Acta Diabetol; 2003 Dec; 40 Suppl 2():S343-7. PubMed ID: 14704866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes and acute coronary syndrome.
    Keller PF; Carballo D; Roffi M
    Minerva Med; 2010 Apr; 101(2):81-104. PubMed ID: 20467408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacoinvasive management of acute coronary syndrome: incorporating the 2007 ACC/AHA guidelines: the CATH (cardiac catheterization and antithrombotic therapy in the hospital) Clinical Consensus Panel Report--III.
    Cohen M; Diez JE; Levine GN; Ferguson JJ; Morrow DA; Rao SV; Zidar JP; ;
    J Invasive Cardiol; 2007 Dec; 19(12):525-38; quiz 539-40. PubMed ID: 18180524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.